iEAAsynBIO: Precision nutrition by Ling Ma, PhD. Bridging the gap between Organic Chemistry, Nanomedicine, and Muscle Health for global longevity.

iEAAsynBIO

Empowering Longevity through Precision Nutrition

Leveraging advanced food science and nutraceutical innovation to redefine muscle health and metabolic wellness for a global population

Bridging the Gap in Healthy Aging

As the global population ages, maintaining muscle mass and metabolic integrity has become the new frontier of preventative health. At iEAAsynBIO, we are developing a next-generation formulation platform designed to support muscle protein synthesis and metabolic efficiency.

Our approach combines rigorous scientific research with a deep understanding of ingredient synergy to create solutions that are both effective and scalable.

Founded in Science. Driven by Innovation

iEAAsynBIO was founded by Ling Ma, PhD, a veteran of the global food ingredient and biotechnology industries. With a doctorate in Organic Chemistry and early-career roots in nanomedicine for cancer treatment and diabetes drug development, Dr. Ma brings pharmaceutical-level rigor to the world of nutrition.

Leveraging over 20 years of leadership at global giants like Givaudan, Coca-Cola, DSM-Firmenich, Tate & Lyle, and Ingredion, she leads iEAAsynBIO with a "Molecular-First" philosophy. We specialize in the intersection of:

Precision Amino Acid Profiles: Optimizing essential building blocks for cellular health.
Bio-Harmonization: Ensuring ingredient compatibility and maximum metabolic efficacy.
Advanced Delivery Systems: Utilizing a background in nanomedicine to redefine how nutrients are absorbed and utilized.

Innovation in Motion

Our core technology platform is currently under proprietary development, with international patents pending (PCT). We are actively exploring strategic partnerships with global distributors, healthcare providers, and nutrition brands who share our commitment to evidence-based longevity.

Let's Shape the Future of Nutrition

Interested in learning more about our development roadmap or exploring partnership opportunities?

Page updated

Report abuse